Challenges & Solutions: Designing ePRO and eConsent for Pediatric Trials Webinar

July 25, 2024
-
50
Min Read

Unlocking the Full Potential of Pediatric Clinical Trials 

Pediatric studies come with their own unique data collection challenges. 

In this webinar, we examine how focusing on the trial experience for child participants and their parents will ease their burden and improve the quality and reliability of the data collected. 

This webinar gives you the tools to feel confident in making your next pediatric trial more successful by using the technology we discuss to solve the challenges you face in your pediatric studies. 

What we discussed: 

  • The difficult task of being a “clinical trial family” 
  • Enrollment and retention friction points and how to solve them 
  • 21 CFR Part 11 compliance woes 
  • Working most effectively with kids under 13 
  • Meeting state and international requirements 
  • Multi-user workflows 
  • And lots more! 

Key Takeaways:

  • The challenges in conducting pediatric studies require solutions that make the study process easier for participants and their families.
  • Technology plays a crucial role in simplifying logistics, providing flexibility, and ensuring a seamless experience for pediatric trial participants.
  • Informed consent is a critical aspect of pediatric trials, involving age-appropriate communication and the involvement of parents in the decision-making process.
  • Compliance issues related to privacy, auditability, and 21 CFR part 11 need to be considered, including the use of electronic signatures, audit trails, and authentication methods.
  • Managing young participants and their parents in study participation requires age-appropriate content, flexibility, and personalized experiences.

Watch our on-demand webinar

Guest speaker Gauri Nagrani explores how to make your next clinical trial excel in quality, speed to launch, and user experience. Open to sponsors, investigators, and study teams, the presentation examines valuable insights to enhance your approach to pediatric clinical trials.